Key Takeaways Stem cell therapy for rheumatoid arthritis has real human trial data behind it, not just lab or animal studies. A 3-year study found that disease activity scores significantly
Key Takeaways Novartis paused eight autoimmune and nerve disease trials of its rap-cel CAR-T cell therapy on August 24, 2026. Three patients died from immune effector cell-associated hemophagocytic syndrome (IEC-HS).
Key Takeaways Stem cell therapy for psoriasis is being studied for its ability to calm the immune system, not just treat visible skin symptoms. Mesenchymal stem cells appear to shift
Key Takeaways Stem cell therapy after spinal cord injury is studied for both traumatic and chronic cases, with different goals at each stage. A 2024 study found durable motor and
Key Takeaways A new randomized trial tested injecting mesenchymal stem cells into the spinal fluid of 18 people with progressive MS. The trial’s main measure of nerve repair did not
Key Takeaways Stem cell therapy for sports injuries is often explored for meniscus tears that have not responded well to rest, physio, or PRP alone. A 2026 phase III trial
